DAVID H PERSING Insider Trading $CPHD CEPHEID
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID H PERSING.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID H PERSING. DAVID H PERSING is Director in CEPHEID ($CPHD) and EVP, Chief Med/Tech Officer in CEPHEID ($CPHD) and Exec VP,Chief Med/Tech Officer in CEPHEID ($CPHD).
DAVID H PERSING in CEPHEID
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of DAVID H PERSING: EVP, Chief Med/Tech Officer, Exec VP,Chief Med/Tech Officer, Director
Holdings: 4,687 shares
Latest Transaction: Feb 02 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DAVID H PERSING in CEPHEID
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 02 2015 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Option Exercise | M | 0.00 | 365 | 0 | 3,291 | |
| Feb 02 2015 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Payment of Exercise | F | 54.09 | 138 | 7,464 | 4,687 | 4.8 K to 4.7 K (-2.86 %) |
| Feb 02 2015 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Buy | M | 0.00 | 365 | 0 | 4,825 | 4.5 K to 4.8 K (+8.18 %) |
| Jan 27 2015 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Option Exercise | M | 0.00 | 302 | 0 | 302 | |
| Jan 27 2015 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Option Exercise | M | 0.00 | 338 | 0 | 1,693 | |
| Jan 27 2015 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Payment of Exercise | F | 55.02 | 114 | 6,272 | 4,460 | 4.6 K to 4.5 K (-2.49 %) |
| Jan 27 2015 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Buy | M | 0.00 | 302 | 0 | 4,574 | 4.3 K to 4.6 K (+7.07 %) |
| Jan 27 2015 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Payment of Exercise | F | 55.02 | 128 | 7,043 | 4,272 | 4.4 K to 4.3 K (-2.91 %) |
| Jan 27 2015 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Buy | M | 0.00 | 338 | 0 | 4,400 | 4.1 K to 4.4 K (+8.32 %) |
| Jan 14 2015 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Option Exercise | M | 8.43 | 5,000 | 42,150 | 5,000 | |
| Jan 14 2015 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Sell | S | 56.90 | 5,000 | 284,500 | 4,062 | 9.1 K to 4.1 K (-55.18 %) |
| Jan 14 2015 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Buy | M | 8.43 | 5,000 | 42,150 | 9,062 | 4.1 K to 9.1 K (+123.09 %) |
| Dec 02 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Option Exercise | M | 8.43 | 15,000 | 126,450 | 10,000 | |
| Dec 02 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Sell | S | 56.34 | 5,000 | 281,700 | 4,062 | 9.1 K to 4.1 K (-55.18 %) |
| Dec 02 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Sell | S | 55.78 | 5,000 | 278,900 | 9,062 | 14.1 K to 9.1 K (-35.56 %) |
| Dec 02 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Sell | S | 55.23 | 5,000 | 276,150 | 14,062 | 19.1 K to 14.1 K (-26.23 %) |
| Dec 02 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Buy | M | 8.43 | 15,000 | 126,450 | 19,062 | 4.1 K to 19.1 K (+369.28 %) |
| Dec 01 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Option Exercise | M | 19.85 | 75,000 | 1,488,750 | 0 | |
| Dec 01 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Sell | S | 54.62 | 75,000 | 4,096,223 | 4,062 | 79.1 K to 4.1 K (-94.86 %) |
| Dec 01 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Buy | M | 19.85 | 75,000 | 1,488,750 | 79,062 | 4.1 K to 79.1 K (+1,846.38 %) |
| Nov 17 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Option Exercise | M | 8.43 | 5,000 | 42,150 | 25,000 | |
| Nov 17 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Sell | S | 54.68 | 5,000 | 273,400 | 4,062 | 9.1 K to 4.1 K (-55.18 %) |
| Nov 17 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Buy | M | 8.43 | 5,000 | 42,150 | 9,062 | 4.1 K to 9.1 K (+123.09 %) |
| Oct 31 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Option Exercise | M | 8.43 | 5,000 | 42,150 | 30,000 | |
| Oct 31 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Option Exercise | M | 8.43 | 15,000 | 126,450 | 35,000 | |
| Oct 31 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Option Exercise | M | 0.00 | 366 | 0 | 3,656 | |
| Oct 31 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Sell | S | 54.14 | 5,000 | 270,700 | 4,062 | 9.1 K to 4.1 K (-55.18 %) |
| Oct 31 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Buy | M | 8.43 | 5,000 | 42,150 | 9,062 | 4.1 K to 9.1 K (+123.09 %) |
| Oct 31 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Sell | S | 53.60 | 5,000 | 268,000 | 4,062 | 9.1 K to 4.1 K (-55.18 %) |
| Oct 31 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Sell | S | 53.07 | 5,000 | 265,350 | 9,062 | 14.1 K to 9.1 K (-35.56 %) |
| Oct 31 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Sell | S | 52.55 | 5,000 | 262,750 | 14,062 | 19.1 K to 14.1 K (-26.23 %) |
| Oct 31 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Buy | M | 8.43 | 15,000 | 126,450 | 19,062 | 4.1 K to 19.1 K (+369.28 %) |
| Oct 31 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Payment of Exercise | F | 51.90 | 138 | 7,162 | 4,062 | 4.2 K to 4.1 K (-3.29 %) |
| Oct 31 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Buy | M | 0.00 | 366 | 0 | 4,200 | 3.8 K to 4.2 K (+9.55 %) |
| Oct 28 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Option Exercise | M | 8.43 | 5,000 | 42,150 | 50,000 | |
| Oct 28 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Option Exercise | M | 8.43 | 10,000 | 84,300 | 55,000 | |
| Oct 28 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Option Exercise | M | 0.00 | 302 | 0 | 604 | |
| Oct 28 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Option Exercise | M | 0.00 | 339 | 0 | 2,031 | |
| Oct 28 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Sell | S | 52.03 | 5,000 | 260,150 | 3,834 | 8.8 K to 3.8 K (-56.60 %) |
| Oct 28 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Buy | M | 8.43 | 5,000 | 42,150 | 8,834 | 3.8 K to 8.8 K (+130.41 %) |
| Oct 28 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Sell | S | 51.51 | 5,000 | 257,550 | 3,834 | 8.8 K to 3.8 K (-56.60 %) |
| Oct 28 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Sell | S | 51.00 | 5,000 | 255,000 | 8,834 | 13.8 K to 8.8 K (-36.14 %) |
| Oct 28 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Buy | M | 8.43 | 10,000 | 84,300 | 13,834 | 3.8 K to 13.8 K (+260.82 %) |
| Oct 28 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Payment of Exercise | F | 50.08 | 114 | 5,709 | 3,834 | 3.9 K to 3.8 K (-2.89 %) |
| Oct 28 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Buy | M | 0.00 | 302 | 0 | 3,948 | 3.6 K to 3.9 K (+8.28 %) |
| Oct 28 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Payment of Exercise | F | 50.08 | 128 | 6,410 | 3,646 | 3.8 K to 3.6 K (-3.39 %) |
| Oct 28 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Buy | M | 0.00 | 339 | 0 | 3,774 | 3.4 K to 3.8 K (+9.87 %) |
| Jul 31 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Option Exercise | M | 0.00 | 365 | 0 | 4,022 | |
| Jul 31 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Payment of Exercise | F | 39.50 | 138 | 5,451 | 3,340 | 3.5 K to 3.3 K (-3.97 %) |
| Jul 31 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Buy | M | 0.00 | 365 | 0 | 3,478 | 3.1 K to 3.5 K (+11.73 %) |
| Jul 28 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Option Exercise | M | 0.00 | 302 | 0 | 906 | |
| Jul 28 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Option Exercise | M | 0.00 | 338 | 0 | 2,370 | |
| Jul 28 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Payment of Exercise | F | 39.47 | 114 | 4,500 | 3,113 | 3.2 K to 3.1 K (-3.53 %) |
| Jul 28 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Buy | M | 0.00 | 302 | 0 | 3,227 | 2.9 K to 3.2 K (+10.32 %) |
| Jul 28 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Payment of Exercise | F | 40.55 | 128 | 5,190 | 2,925 | 3.1 K to 2.9 K (-4.19 %) |
| Jul 28 2014 | CPHD | CEPHEID | PERSING DAVID H | EVP, Chief Med/Tech ... | Buy | M | 0.00 | 338 | 0 | 3,053 | 2.7 K to 3.1 K (+12.45 %) |
| Apr 30 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 1,463 | 0 | 4,387 | |
| Apr 30 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 339 | 0 | 0 | |
| Apr 30 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 42.14 | 550 | 23,177 | 2,715 | 3.3 K to 2.7 K (-16.85 %) |
| Apr 30 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 1,463 | 0 | 3,265 | 1.8 K to 3.3 K (+81.19 %) |
| Apr 30 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 42.14 | 128 | 5,394 | 1,802 | 1.9 K to 1.8 K (-6.63 %) |
| Apr 30 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 339 | 0 | 1,930 | 1.6 K to 1.9 K (+21.31 %) |
| Apr 25 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 302 | 0 | 1,208 | |
| Apr 25 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 339 | 0 | 2,708 | |
| Apr 25 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 42.02 | 114 | 4,790 | 1,591 | 1.7 K to 1.6 K (-6.69 %) |
| Apr 25 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 302 | 0 | 1,705 | 1.4 K to 1.7 K (+21.53 %) |
| Apr 25 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 43.55 | 128 | 5,574 | 1,403 | 1.5 K to 1.4 K (-8.36 %) |
| Apr 25 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 339 | 0 | 1,531 | 1.2 K to 1.5 K (+28.44 %) |
| Apr 23 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | A | 45.84 | 41,250 | 1,890,900 | 41,250 | |
| Apr 23 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | A | 0.00 | 4,500 | 0 | 4,500 | |
| Jan 30 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 338 | 0 | 339 | |
| Jan 30 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 46.56 | 149 | 6,937 | 1,192 | 1.3 K to 1.2 K (-11.11 %) |
| Jan 30 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 338 | 0 | 1,341 | 1 K to 1.3 K (+33.70 %) |
| Jan 28 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 302 | 0 | 1,510 | |
| Jan 28 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 338 | 0 | 3,047 | |
| Jan 28 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 48.11 | 133 | 6,399 | 1,003 | 1.1 K to 1 K (-11.71 %) |
| Jan 28 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 302 | 0 | 1,136 | 834 to 1.1 K (+36.21 %) |
| Jan 28 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 48.11 | 149 | 7,168 | 834 | 983 to 834 (-15.16 %) |
| Jan 28 2014 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 338 | 0 | 983 | 645 to 983 (+52.40 %) |
| Nov 18 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 11.94 | 5,000 | 59,700 | 0 | |
| Nov 18 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 42.18 | 5,000 | 210,900 | 645 | 5.6 K to 645 (-88.57 %) |
| Nov 18 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 11.94 | 5,000 | 59,700 | 5,645 | 645 to 5.6 K (+775.19 %) |
| Nov 13 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 11.94 | 5,000 | 59,700 | 5,000 | |
| Nov 13 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 41.76 | 5,000 | 208,800 | 645 | 5.6 K to 645 (-88.57 %) |
| Nov 13 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 11.94 | 5,000 | 59,700 | 5,645 | 645 to 5.6 K (+775.19 %) |
| Oct 30 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 11.94 | 5,000 | 59,700 | 10,000 | |
| Oct 30 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 339 | 0 | 677 | |
| Oct 30 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 41.35 | 5,000 | 206,750 | 645 | 5.6 K to 645 (-88.57 %) |
| Oct 30 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 11.94 | 5,000 | 59,700 | 5,645 | 645 to 5.6 K (+775.19 %) |
| Oct 30 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 40.91 | 177 | 7,241 | 645 | 822 to 645 (-21.53 %) |
| Oct 30 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 339 | 0 | 822 | 483 to 822 (+70.19 %) |
| Oct 28 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 302 | 0 | 1,812 | |
| Oct 28 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 339 | 0 | 3,385 | |
| Oct 28 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 40.48 | 158 | 6,396 | 483 | 641 to 483 (-24.65 %) |
| Oct 28 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 302 | 0 | 641 | 339 to 641 (+89.09 %) |
| Oct 28 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 40.26 | 177 | 7,126 | 339 | 516 to 339 (-34.30 %) |
| Oct 28 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 339 | 0 | 516 | 177 to 516 (+191.53 %) |
| Oct 22 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 11.94 | 20,000 | 238,800 | 15,000 | |
| Oct 22 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 40.94 | 5,000 | 204,700 | 177 | 5.2 K to 177 (-96.58 %) |
| Oct 22 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 40.53 | 5,000 | 202,650 | 5,177 | 10.2 K to 5.2 K (-49.13 %) |
| Oct 22 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 40.45 | 10,000 | 404,500 | 10,177 | 20.2 K to 10.2 K (-49.56 %) |
| Oct 22 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 11.94 | 20,000 | 238,800 | 20,177 | 177 to 20.2 K (+11,299.44 %) |
| Sep 19 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 11.94 | 5,000 | 59,700 | 35,000 | |
| Sep 19 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 39.34 | 5,000 | 196,700 | 177 | 5.2 K to 177 (-96.58 %) |
| Sep 19 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 11.94 | 5,000 | 59,700 | 5,177 | 177 to 5.2 K (+2,824.86 %) |
| Sep 18 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 11.94 | 5,000 | 59,700 | 40,000 | |
| Sep 18 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 38.95 | 5,000 | 194,750 | 177 | 5.2 K to 177 (-96.58 %) |
| Sep 18 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 11.94 | 5,000 | 59,700 | 5,177 | 177 to 5.2 K (+2,824.86 %) |
| Sep 09 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 11.94 | 5,000 | 59,700 | 45,000 | |
| Sep 09 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 11.94 | 10,000 | 119,400 | 50,000 | |
| Sep 09 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.35 | 5,000 | 36,750 | 0 | |
| Sep 09 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 38.56 | 5,000 | 192,800 | 177 | 5.2 K to 177 (-96.58 %) |
| Sep 09 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 11.94 | 5,000 | 59,700 | 5,177 | 177 to 5.2 K (+2,824.86 %) |
| Sep 09 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 38.18 | 5,000 | 190,900 | 177 | 5.2 K to 177 (-96.58 %) |
| Sep 09 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 37.80 | 5,000 | 189,000 | 5,177 | 10.2 K to 5.2 K (-49.13 %) |
| Sep 09 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 37.43 | 5,000 | 187,150 | 10,177 | 15.2 K to 10.2 K (-32.94 %) |
| Sep 09 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 11.94 | 10,000 | 119,400 | 15,177 | 5.2 K to 15.2 K (+193.16 %) |
| Sep 09 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.35 | 5,000 | 36,750 | 5,177 | 177 to 5.2 K (+2,824.86 %) |
| Sep 04 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 36.62 | 5,129 | 187,824 | 177 | 5.3 K to 177 (-96.66 %) |
| Jul 30 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 338 | 0 | 1,016 | |
| Jul 30 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 34.44 | 128 | 4,408 | 5,293 | 5.4 K to 5.3 K (-2.36 %) |
| Jul 30 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 338 | 0 | 5,421 | 5.1 K to 5.4 K (+6.65 %) |
| Jul 25 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 302 | 0 | 2,114 | |
| Jul 25 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 338 | 0 | 3,724 | |
| Jul 25 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 34.53 | 114 | 3,936 | 5,083 | 5.2 K to 5.1 K (-2.19 %) |
| Jul 25 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 302 | 0 | 5,197 | 4.9 K to 5.2 K (+6.17 %) |
| Jul 25 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 33.80 | 128 | 4,326 | 4,895 | 5 K to 4.9 K (-2.55 %) |
| Jul 25 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 338 | 0 | 5,023 | 4.7 K to 5 K (+7.21 %) |
| May 01 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | A | 38.66 | 52,500 | 2,029,650 | 52,500 | |
| May 01 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | A | 0.00 | 5,850 | 0 | 5,850 | |
| May 01 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 339 | 0 | 1,354 | |
| May 01 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 38.66 | 128 | 4,948 | 4,685 | 4.8 K to 4.7 K (-2.66 %) |
| May 01 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 339 | 0 | 4,813 | 4.5 K to 4.8 K (+7.58 %) |
| Apr 25 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 302 | 0 | 2,416 | |
| Apr 25 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 1,355 | 0 | 4,062 | |
| Apr 25 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 38.42 | 114 | 4,380 | 4,474 | 4.6 K to 4.5 K (-2.48 %) |
| Apr 25 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 302 | 0 | 4,588 | 4.3 K to 4.6 K (+7.05 %) |
| Apr 25 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 37.95 | 510 | 19,355 | 4,286 | 4.8 K to 4.3 K (-10.63 %) |
| Apr 25 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 1,355 | 0 | 4,796 | 3.4 K to 4.8 K (+39.38 %) |
| Feb 25 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 15,000 | 110,700 | 0 | |
| Feb 25 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 36.13 | 15,000 | 541,994 | 3,441 | 18.4 K to 3.4 K (-81.34 %) |
| Feb 25 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 15,000 | 110,700 | 18,441 | 3.4 K to 18.4 K (+435.92 %) |
| Jan 30 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 338 | 0 | 1,693 | |
| Jan 30 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 36.09 | 149 | 5,377 | 3,359 | 3.5 K to 3.4 K (-4.25 %) |
| Jan 30 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 338 | 0 | 3,508 | 3.2 K to 3.5 K (+10.66 %) |
| Jan 28 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 302 | 0 | 2,718 | |
| Jan 28 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 37.83 | 133 | 5,031 | 3,170 | 3.3 K to 3.2 K (-4.03 %) |
| Jan 28 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 302 | 0 | 3,303 | 3 K to 3.3 K (+10.06 %) |
| Oct 31 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 339 | 0 | 2,031 | |
| Oct 31 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 30.46 | 159 | 4,843 | 3,001 | 3.2 K to 3 K (-5.03 %) |